Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 16 10:28AM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-9.04 Insider Own12.19% Shs Outstand8.58M Perf Week20.53%
Market Cap8.87M Forward P/E- EPS next Y-3.68 Insider Trans0.00% Shs Float8.28M Perf Month-15.31%
Income-71.05M PEG- EPS next Q-1.45 Inst Own13.94% Short Float3.28% Perf Quarter-50.78%
Sales3.02M P/S2.94 EPS this Y28.97% Inst Trans76.73% Short Ratio4.56 Perf Half Y-71.43%
Book/sh-8.11 P/B- EPS next Y43.44% ROA-119.87% Short Interest0.27M Perf Year-81.36%
Cash/sh2.71 P/C0.35 EPS next 5Y- ROE- 52W Range0.60 - 7.76 Perf YTD-73.53%
Dividend Est.- P/FCF- EPS past 5Y6.21% ROI- 52W High-87.88% Beta0.67
Dividend TTM- Quick Ratio0.52 Sales past 5Y105.16% Gross Margin-218.63% 52W Low56.71% ATR (14)0.11
Dividend Ex-Date- Current Ratio0.54 EPS Y/Y TTM39.09% Oper. Margin-2069.99% RSI (14)47.46 Volatility10.80% 12.99%
Employees107 Debt/Eq- Sales Y/Y TTM375.71% Profit Margin-2355.87% Recom1.50 Target Price9.75
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q5.78% Payout- Rel Volume1.83 Prev Close0.94
Sales Surprise-4.07% EPS Surprise-56.58% Sales Q/Q126.46% EarningsMay 14 BMO Avg Volume59.57K Price0.94
SMA2014.39% SMA50-29.69% SMA200-61.45% Trades Volume20,816 Change0.01%
Date Action Analyst Rating Change Price Target Change
Mar-30-21Initiated Cantor Fitzgerald Overweight $8
Nov-05-20Initiated Ascendiant Capital Markets Buy $5
Jun-28-18Initiated Maxim Group Buy $5
Jul-11-24 08:31AM
Jul-02-24 07:55AM
Jun-13-24 07:58AM
Jun-12-24 08:05AM
May-14-24 08:21AM
07:53AM Loading…
May-13-24 08:43PM
May-09-24 07:49AM
May-07-24 07:39AM
May-03-24 08:35AM
May-02-24 08:35AM
Apr-30-24 07:35AM
Apr-29-24 08:47AM
06:15PM Loading…
Apr-10-24 06:15PM
Apr-08-24 08:30AM
Mar-28-24 09:47AM
Mar-27-24 12:35PM
Mar-26-24 07:32PM
Mar-25-24 05:30PM
Mar-21-24 09:30AM
Mar-20-24 08:30AM
Mar-13-24 08:30AM
Mar-12-24 08:30AM
Feb-16-24 05:00PM
Feb-15-24 07:45AM
Feb-08-24 07:45AM
08:30AM Loading…
Dec-12-23 08:30AM
Dec-11-23 09:00AM
Dec-05-23 08:55AM
Dec-04-23 04:20PM
Dec-01-23 10:00AM
Nov-20-23 12:44PM
Nov-16-23 09:07AM
Nov-14-23 05:43PM
Nov-13-23 05:40PM
Nov-09-23 09:00AM
Nov-02-23 09:18AM
Nov-01-23 09:10AM
Oct-31-23 09:00AM
Sep-21-23 08:30AM
Sep-07-23 09:20AM
Sep-06-23 09:00AM
Aug-30-23 09:55AM
Aug-24-23 09:00AM
Aug-22-23 05:30PM
Aug-17-23 03:39AM
Aug-15-23 08:17PM
Aug-14-23 06:48PM
Jul-31-23 06:19PM
Jul-26-23 08:30AM
Jul-19-23 09:04AM
Jun-28-23 04:05PM
Jun-14-23 04:05PM
Jun-05-23 07:00AM
Jun-02-23 07:00AM
May-24-23 08:00AM
May-18-23 12:03PM
May-16-23 05:00PM
May-15-23 06:21PM
May-11-23 08:45AM
May-05-23 09:00AM
Apr-25-23 08:45AM
Apr-19-23 08:45AM
Apr-17-23 09:45PM
Mar-31-23 12:45PM
Mar-20-23 09:03PM
Mar-17-23 12:00PM
Mar-16-23 01:22AM
Mar-14-23 07:09PM
Mar-03-23 08:15AM
Feb-28-23 08:30AM
Feb-15-23 09:55AM
Jan-18-23 06:24AM
Jan-17-23 04:05PM
Jan-11-23 08:00AM
Dec-22-22 08:25AM
Dec-15-22 08:25AM
Dec-08-22 08:25AM
Dec-01-22 08:25AM
Nov-15-22 04:20PM
Nov-14-22 04:40PM
Nov-11-22 08:25AM
Nov-10-22 08:25AM
Nov-09-22 08:25AM
Nov-03-22 08:25AM
Nov-02-22 08:25AM
Aug-30-22 08:25AM
PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. It operates through the following divisions: Medical Devices, Diagnostics, Digital Health, and Emerging Innovations. The company's products include cell collection devices, esophageal DNA tests, carpal tunnel release, implantable intraosseous vascular access devices, and antimicrobial resorbable ear tubes. PAVmed was founded on June 26, 2014 and is headquartered in New York, NY.